References
- Ng SC, Bernstein CN, Vatn MH, et al., on behalf of the Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD). Recent advances in clinical practice: geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630–649.
- Aamodt G, Bukholm G, Jahnsen J, et al., IBSEN Study Group. The association between water supply and inflammatory bowel disease based on a 1990–1993 cohort study in southeastern Norway. Am J Epidemiol. 2008;168:1065–1072.
- Pugazhendhi S, Sahu MK, Subramanian V, et al. Environmental factors associated with Crohn’s disease in India. Indian J Gastroenterol. 2011;30:264–269.
- Ananthakrishnan AN, McGinley EL, Binion DG, et al. Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. Inflamm Bowel Dis. 2011;17:1138–1145.
- Chess S, Chess D, Olander G, et al. Production of chronic enteritis and other systemic lesions by ingestion of finely divided foreign materials. Surgery. 1950;27:221–234.
- Sullivan SN. Hypothesis revisited: toothpaste and the cause of Crohn’s disease. Lancet 1990;336:1096–1097.
- Singhal S, Dian D, Keshavarzian A, et al. The role of oral hygiene in inflammatory bowel disease. Dig Dis Sci. 2011;56:170–175.
- Yadav AK, Kaushik CP, Haritash AK, et al. Determination of exposure and probable ingestion of fluoride through tea, toothpaste, tobacco and pan masala. J Hazard Mater. 2007;142:77–80.
- Macleod JJR. Blood glycolysis: its extent and significance in carbohydrate metabolism. The supposed existence of “sucre virtuel” in freshly drawn blood. J Biol Chem. 1913;15:497–514.
- Gordon JA. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Meth Enzymol. 1991;201:477–482.
- Sternweis PC, Gilman AG. Aluminum: a requirement for activation of the regulatory component of adenylate cyclase by fluoride. Proc Natl Acad Sci USA. 1982;79:4888–4891.
- Whitford GM. Intake and metabolism of fluoride. Adv Dent Res. 1994;8:5–14.
- Dabeka RW, MacKenzie AD, Lacroix GMA. Dietary intakes of lead, cadmium, arsenic and fluoride by Canadian adults: a 24-hour duplicate diet study . Food Addit Contam. 1987;4:89–101.
- Rocha RA, Devesa V, Vélez D. In vitro study of intestinal transport of fluoride using the Caco-2 cell line. Food Chem Toxicol. 2013;55:156–163.
- Trautner K, Einwag J. Influence of milk and food on fluoride bioavailability from NaF and Na2FPO3 in man. J Dent Res. 1989;68:72–77.
- Rabb-Waytowich D. Water fluoridation in Canada: past and present; [cited 2015 Nov 3]. Available from: www.cda-adc.ca/jcda/vol-75/issue-6/451.html.
- Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006;101:1559–1568.
- Benchimol EI, Manuel DG, Guttmann A, et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis. 2014;20:1761–1769.
- Bitton A, Vutcovici M, Patenaude V, et al. Epidemiology of inflammatory bowel disease in Québec: recent trends. Inflamm Bowel Dis. 2014;20:1770–1776.
- Assemblée nationale du Québec archives database; [cited 2015 Nov 3]. Available from: http://www.assnat.qc.ca.
- Michel P, St-Onge L, Lowe AM, et al. Geographical variation of Crohn’s disease residual incidence in the Province of Quebec, Canada. Int J Health Geogr. 2010;9:22.
- Government of Canada reported pollution database [cited 2015 Nov 3]. Available from: http://www.ec.gc.ca/inrp-npri/donnees-data/index.cfm?lang=En.
- Boyle DR, Chagnon M. An incidence of skeletal fluorosis associated with groundwaters of the maritime carboniferous basin, Gaspé region, Quebec, Canada. Environ Geochem Health. 1995;17:5–12.
- Cottone M, Renda MC, Mattaliano A, et al. Incidence of Crohn’s disease and CARD15 mutation in a small township in Sicily. Eur J Epidemiol. 2006;21:887–892.
- D’Alessandro W, Bellomo S, Parello F, et al. Survey on fluoride, bromide and chloride contents in public drinking water supplies in Sicily (Italy). Environ Monit Assess. 2008;145:303–313.
- Frada G, Mentesana G, Guaijani U. Thyroid function in endemic hydrofluorosis in Sicily. Fluoride. 1969;2:195–200.
- Molodecky NA, Soon S, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.
- Reference Statistics on Water Fluoridation Status archives [cited 2015 Nov 3]. Available from: http://www.cdc.gov/fluoridation/statistics/reference_stats.htm.
- Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology. 1990;98:104–110.
- Qin X. Etiology of inflammatory bowel disease: a unified hypothesis. World J Gastroenterol. 2012;18:1708–1722.
- Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13:254–261.
- Altrec-Williams S. Water fluoridation in New South Wales, 1956–1971. Aust Dent J. 1972;17:196–203.
- Pinchbeck BR, Kirdeikis J, Thomson ABR. Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol. 1988;10:505–515.
- Phavichitr N, Cameron DJ, Catto-Smith AG. Increasing incidence of Crohn’s disease in Victorian children. J Gastroenterol Hepatol. 2003;18:329–332.
- Anseline PF. Crohn’s disease in the Hunter Valley region of Australia. Aust NZ J Surg. 1995;65:564–569.
- Steenland K, Zhao L, Winquist A, et al. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the Mid-Ohio Valley. Environ Health Perspect. 2013;121:900–905.
- United States Environmental Protection Agency Tri explorer 2014 dataset; [cited 2015 Nov 19]. Available from: http://www.epa.gov/triexplorer.
- Li X, Sundquist J, Sundquist K. Educational level and occupation as risk factors for inflammatory bowel diseases: A nationwide study based on hospitalizations in Sweden. Inflamm Bowel Dis. 2009;15:608–615.
- Sweden pollutant release and transfer register database; [cited Nov 17]. Available from: http://utslappisiffror.naturvardsverket.se.
- Ehrnebo M, Ekstrand J. Occupational fluoride exposure and plasma fluoride levels in man. Int Arch Occup Environ Health. 1986;58:179–190.
- Perumal E, Paul V, Govindarajan V, et al. A brief review on experimental fluorosis. Toxicol Lett. 2013;223:236–251.
- Butler JE, Satam M, Ekstrand J. Fluoride: an adjuvant for mucosal and systemic immunity. Immunol Lett. 1990;26:217–220.
- Chauhan SS, Mahmood A, Ojha S. Ethanol and age enhances fluoride toxicity through oxidative stress and mitochondrial dysfunctions in rat intestine. Mol Cell Biochem. 2013;384:251–262.
- Liu J, Cui H, Peng X, et al. Dietary high fluorine induces apoptosis and alters Bcl-2, Bax, and caspase-3 protein expression in the cecal tonsil lymphocytes of broilers. Biol Trace Elem Res. 2013;152:25–30.
- Roholm K. Fluorine intoxication. A clinical-hygiene study. London: H.K. Lewis; 1937.
- Sood A, Midha V, Sood N, et al. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut. 2003;52:1587–1590.
- Susheela AK, Mondal NK, Tripathi N, et al. Early diagnosis and complete recovery from fluorosis through practice of interventions. JAPI. 2014;62:573.
- Susheela AK, Kumar A, Bhatnagar M, et al. Prevalence of endemic fluorosis with gastro-intestinal manifestations in people living in some North-Indian villages. Fluoride. 1993;26:97–104.
- Gupta IP, Das TK, Susheela AK, et al. Fluoride as a possible aetiological factor in non-ulcer dyspepsia. J Gastroenterol Hepatol. 1992;7:355–359.
- Dasarathy S, Das TK, Gupta IP, et al. Gastroduodenal manifestations in patients with skeletal fluorosis. J Gastroenterol. 1996;31:333–337.
- Sharma JD, Jain P, Sohu D. Gastric discomforts from fluoride in drinking water in Sanganer Tehsil, Rajasthan, India. Fluoride. 2009;42:286–291.
- Chahal A, Bala M, Dahiya RS, et al. Comparative evaluation of serum fluoride levels in patients with and without chronic abdominal pain. Clin Chim Acta. 2014;429:140–142.
- Yasmin S, Ranjan S, D’Souza D. Haematological changes in fluorotic adults and children in fluoride endemic regions of Gaya district, Bihar, India. Environ Geochem Health. 2014;36:421–425.
- Gupta R, Kumar AN, Bandhu S, et al. Skeletal fluorosis mimicking seronegative arthritis. Scand J Rheumatol. 2007;36:154–155.
- Boulétreau PH, Bost M, Fontanges E, et al. Fluoride exposure and bone status in patients with chronic intestinal failure who are receiving home parenteral nutrition. Am J Clin Nutr. 2006;83:1429–1437.
- Baker JL, Sudarsan N, Weinberg Z, et al. Widespread genetic switches and toxicity resistance proteins for fluoride. Science. 2012;335:233–235.
- Stockbridge RB, Robertson JL, Kolmakova-Partensky L, et al. A family of fluoride-specific ion channels with dual-topology architecture. Elife. 2013;2:e01084.
- Stockbridge RB, Lim HH, Otten R, et al. Fluoride resistance and transport by riboswitch-controlled CLC antiporters. Proc Natl Acad Sci USA. 2012;109:15289–15294.
- Brammer AE, Stockbridge RB, Miller C. F−/Cl− selectivity in CLCF-type F−/H+ antiporters. J Gen Physiol. 2014;144:129–136.
- Ji C, Stockbridge RB, Miller CJ. Bacterial fluoride resistance, Fluc channels, and the weak acid accumulation effect. J Gen Physiol. 2014;144:257–261.
- Erickson AR, Cantarel BL, Lamendella R, et al. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn’s disease. PLoS One. 2012;7:e49138.
- Vejborg RM, Hancock V, Petersen AM, et al. Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease. BMC Genom. 2011;12:316.
- McPhee JB, Small CL, Reid-Yu SA, et al. Host defense peptide resistance contributes to colonization and maximal intestinal pathology by Crohn’s disease-associated adherent-invasive Escherichia coli. Infect Immun. 2014;82:3383–3393.
- Clarke DJ, Chaudhuri RR, Martin HM, et al. Complete genome sequence of the Crohn’s disease-associated adherent-invasive Escherichia coli strain HM605. J Bacteriol. 2011;193:4540.
- Kojima A, Nakano K, Wada K, et al. Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci Rep. 2012;2:332.
- Liao Y, Chen J, Brandt BW, et al. Identification and functional analysis of genome mutations in a fluoride-resistant Streptococcus mutans strain. PLoS One. 2015;10:e0122630.
- Hemarajata P, Spinler JK, Balderas MA, et al. Identification of a proton-chloride antiporter (EriC) by Himar1 transposon mutagenesis in Lactobacillus reuteri and its role in histamine production. Antonie Van Leeuwenhoek. 2014;105:579–592.
- Nighot P, Young K, Nighot M, et al. Chloride channel ClC-2 is a key factor in the development of DSS-induced murine colitis. Inflamm Bowel Dis. 2013;19:2867–2877.
- Younggeon J, Pridgeon T, Blikslager A. Lubiprostone reduces murine colitis principally in a ClC-2-dependent manner (LB750). FASEB J. 2014:28;LB750.
- Huang LY, He Q, Liang SJ, et al. ClC-3 chloride channel/antiporter defect contributes to inflammatory bowel disease in humans and mice. Gut. 2014;63:1587–1595.
- Alex P, Ye M, Zachos NC, et al. Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis. J Immunol. 2010;184:3988–3996.
- Powell JJ, Thomas-McKay E, Thoree V, et al. An endogenous nanomineral chaperones luminal antigen and peptidoglycan to intestinal immune cells. Nat Nanotechnol. 2015;10:361–369.
- Chowdhury EH. Fluoride enhances transfection activity of carbonate apatite by increasing cytoplasmic stability of plasmid DNA. Biochem Biophys Res Commun. 2011;409:745–747.
- Pineton de Chambrun G, Body-Malapel M, Frey-Wagner I, et al. Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice. Mucosal Immunol. 2014;7:589–601.
- Spencer H, Kramer L, Norris C, et al. Effect of aluminum hydroxide on fluoride metabolism. Clin Pharmacol Ther. 1980;28:529–535.
- Sturr MG, Marquis RE. Inhibition of proton-translocating ATPases of Streptococcus mutans and Lactobacillus casei by fluoride and aluminium. Arch Microbiol. 1990;155:22–27.
- Martinez-Mier EA, Soto-Rojas AE. Differences in exposure and biological markers of fluoride among White and African American children. J Public Health Dent. 2010;70:234–240.
- Duursma SA, Raymakers JA, De Raadt ME, et al. Urinary fluoride excretion in responders and nonresponders after fluoride therapy in osteoporosis. J Bone Miner Res. 1990;5:S43–S47.
- Wu J, Wang W, Liu Y, et al. Modifying role of GSTP1 polymorphism on the association between tea fluoride exposure and the brick-tea type fluorosis. PLoS One. 2015;10:e0128280.
- Zhang T, Shan KR, Tu X, et al. Myeloperoxidase activity and its corresponding mRNA expression as well as gene polymorphism in the population living in the coal-burning endemic fluorosis area in Guizhou of China. Biol Trace Elem Res. 2013;152:379–386.
- Committee on Fluoride in Drinking Water, National Research Council. Effects on the gastrointestinal, renal, hepatic and immune system fluoride. In: Drinking water: a scientific review of EPA’s standards. The National Academies Press; 2006. p. 268–303.